Works by Cannon, Donald M.


Results: 13
    1
    2

    Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma.

    Published in:
    Current Oncology, 2025, v. 32, n. 3, p. 144, doi. 10.3390/curroncol32030144
    By:
    • Williamson, Julie;
    • Fadlullah, Muhammad Zaki Hidayatullah;
    • Kovacsovics-Bankowski, Magdalena;
    • Gibson, Berit;
    • Swami, Umang;
    • Erickson-Wayman, Alyssa;
    • Jamison, Debra;
    • Sageser, Dan;
    • Jeter, Joanne;
    • Bowles, Tawnya L.;
    • Cannon, Donald M.;
    • Haaland, Ben;
    • Schroeder, Joyce D.;
    • Nix, David A.;
    • Atkinson, Aaron;
    • Hyngstrom, John;
    • McPherson, Jordan;
    • Tan, Aik-Choon;
    • Hu-Lieskovan, Siwen
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    10
    11
    12
    13